Manchester Capital Management LLC Has $4.04 Million Position in UnitedHealth Group Inc (NYSE:UNH)

Share on StockTwits

Manchester Capital Management LLC grew its position in UnitedHealth Group Inc (NYSE:UNH) by 0.8% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 16,537 shares of the healthcare conglomerate’s stock after buying an additional 125 shares during the quarter. UnitedHealth Group accounts for about 0.5% of Manchester Capital Management LLC’s portfolio, making the stock its 25th largest holding. Manchester Capital Management LLC’s holdings in UnitedHealth Group were worth $4,035,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of the company. Canton Hathaway LLC acquired a new position in UnitedHealth Group during the 1st quarter worth approximately $36,000. Truvestments Capital LLC acquired a new position in UnitedHealth Group during the 1st quarter worth approximately $42,000. Coastal Capital Group Inc. acquired a new position in UnitedHealth Group during the 2nd quarter worth approximately $45,000. Creative Financial Designs Inc. ADV increased its position in UnitedHealth Group by 89.6% during the 1st quarter. Creative Financial Designs Inc. ADV now owns 201 shares of the healthcare conglomerate’s stock worth $50,000 after purchasing an additional 95 shares in the last quarter. Finally, Capital Advisors Ltd. LLC increased its position in UnitedHealth Group by 235.7% during the 2nd quarter. Capital Advisors Ltd. LLC now owns 235 shares of the healthcare conglomerate’s stock worth $57,000 after purchasing an additional 165 shares in the last quarter. Institutional investors own 85.37% of the company’s stock.

UNH traded down $2.53 during trading on Tuesday, reaching $242.18. 174,459 shares of the company’s stock were exchanged, compared to its average volume of 3,223,414. UnitedHealth Group Inc has a one year low of $208.07 and a one year high of $287.94. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 0.62. The stock has a market capitalization of $232.84 billion, a PE ratio of 18.79, a price-to-earnings-growth ratio of 1.31 and a beta of 0.61. The firm has a fifty day moving average price of $251.36 and a two-hundred day moving average price of $247.68.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, July 18th. The healthcare conglomerate reported $3.60 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.46 by $0.14. UnitedHealth Group had a net margin of 5.51% and a return on equity of 25.20%. The firm had revenue of $60.60 billion for the quarter, compared to analyst estimates of $60.59 billion. During the same period in the previous year, the firm posted $3.14 EPS. The company’s revenue for the quarter was up 8.0% compared to the same quarter last year. Sell-side analysts expect that UnitedHealth Group Inc will post 14.84 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be paid a $1.08 dividend. This represents a $4.32 dividend on an annualized basis and a dividend yield of 1.78%. The ex-dividend date of this dividend is Friday, September 13th. UnitedHealth Group’s dividend payout ratio is currently 33.54%.

In other news, Director Richard T. Burke sold 5,000 shares of the company’s stock in a transaction on Thursday, August 8th. The shares were sold at an average price of $246.40, for a total value of $1,232,000.00. Following the sale, the director now directly owns 187,979 shares of the company’s stock, valued at approximately $46,318,025.60. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director William C. Ballard, Jr. sold 12,000 shares of the company’s stock in a transaction on Tuesday, July 23rd. The shares were sold at an average price of $255.31, for a total transaction of $3,063,720.00. Following the completion of the sale, the director now directly owns 61,309 shares in the company, valued at $15,652,800.79. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 37,000 shares of company stock worth $9,195,620. Insiders own 0.82% of the company’s stock.

A number of research firms recently issued reports on UNH. Raymond James upped their price objective on shares of UnitedHealth Group from $265.00 to $300.00 and gave the stock a “buy” rating in a research report on Friday, July 19th. Cantor Fitzgerald set a $310.00 price objective on shares of UnitedHealth Group and gave the stock a “buy” rating in a research report on Friday, July 19th. Cleveland Research reiterated a “buy” rating on shares of UnitedHealth Group in a research report on Monday, July 15th. Oppenheimer set a $312.00 target price on shares of UnitedHealth Group and gave the stock a “buy” rating in a report on Friday, July 19th. Finally, Zacks Investment Research raised shares of UnitedHealth Group from a “sell” rating to a “buy” rating and set a $269.00 target price on the stock in a report on Monday, July 22nd. One analyst has rated the stock with a sell rating, one has given a hold rating and eighteen have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus price target of $295.06.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Article: Ex-Dividend

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Armada Hoffler Properties  & Nam Tai Property  Head-To-Head Review
Armada Hoffler Properties & Nam Tai Property Head-To-Head Review
Critical Comparison: Taro Pharmaceutical Industries  and Genmab A/S
Critical Comparison: Taro Pharmaceutical Industries and Genmab A/S
Critical Comparison: Jerash Holdings   versus Its Rivals
Critical Comparison: Jerash Holdings versus Its Rivals
Comparing Symantec  & Tyler Technologies
Comparing Symantec & Tyler Technologies
LegacyTexas Financial Group  Raised to Buy at BidaskClub
LegacyTexas Financial Group Raised to Buy at BidaskClub
Adverum Biotechnologies  PT Lowered to $8.00 at SunTrust Banks
Adverum Biotechnologies PT Lowered to $8.00 at SunTrust Banks


 
© 2006-2019 Zolmax.